| |
Datawatch received top honors from a distinguished panel of CEOs, CIOs, VCs, analysts and the Healthcare Tech Outlook editorial board, who annually review the top companies in the healthcare analytics space, and select those at the forefront of tackling industry challenges.
The panel selected Datawatch because the company delivers solutions that allow healthcare CIOs to create smarter data infrastructures that are less error-prone. “Datawatch’s Managed Analytics Platform for the healthcare sector is designed to include and handle the entire data lifecycle chain. The platform provides the ability to acquire and prepare any type of data, through automated processes and then visualize it for greater business insights all with the governance and compliance capabilities needed by IT especially in data sensitive industries such as healthcare,” the magazine stated.
“Datawatch Corporation has continued to provide innovative solutions in Healthcare Analytics arena for quite some time thereby reinventing the current landscape. We are happy to showcase them this year due to their excellence in delivering best-of-breed technology-driven solutions,” said Alex D’souza, Managing Editor, Healthcare Tech Outlook. “Datawatch Corporation solutions continued to break new ground within the past year, benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”
Datawatch provides users with a unique all-inclusive approach to visual analytics offering users not only sophisticated tools for self-service data preparation, but also the ability to visualize data in real-time. It is particularly well-suited for healthcare applications because it can track changes to data throughout the analytics process and allows data masking that redacts certain parts of the patient’s information like their Social Security Number, medical history and other details to ensure privacy and security. Datawatch also gives healthcare professionals the ability to acquire, transform and prepare Electronic Data Interchange data or PDF data to assist with revenue cycle management and clinical trial management.
“Our Managed Analytics Platform is all about addressing challenges that CIOs face in hospitals and other industries, with a keen focus on accelerating business outcomes,” said Dan Potter, chief marketing officer of Datawatch Corporation. “We are grateful that Healthcare Tech Outlook recognized our technological innovations.”
About Datawatch Corporation
Datawatch Corporation (datawatch.com) provides the only Managed Analytics Platform that brings together self-service data preparation with visual data discovery. Its software bridges the gap between the ease that business user’s demand and the automation and governance needed by IT. Users can quickly discover key factors that improve their business by transforming data from multi-structured sources, as well as real-time streaming data, into visually rich analytic applications. Organizations of every size, worldwide use Datawatch products, including 93 of the Fortune 100. Datawatch is headquartered in Chelmsford, Massachusetts with offices in New York, London, Frankfurt, Stockholm, Singapore, Melbourne and Manila, and with partners and customers in more than 100 countries worldwide.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any such statements contained herein, including but not limited to those relating to product performance and viability, are based on current expectations, but are subject to a number of risks and uncertainties that may cause actual results to differ materially from expectations. The factors that could cause actual future results to differ materially from current expectations include the following: rapid technological change; Datawatch’s dependence on the introduction of new products and product enhancements and possible delays in those introductions; acceptance of new products by the market, competition in the software industry generally, and in the markets for next generation analytics in particular; and Datawatch’s dependence on its principal products, proprietary software technology and software licensed from third parties. Further information on factors that could cause actual results to differ from those anticipated is detailed in various publicly-available documents, which include, but are not limited to, filings made by Datawatch from time to time with the Securities and Exchange Commission, including but not limited to, those appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2014 and Forms 10-Q for the quarters ending December 31, 2014 and March 31, 2015. Any forward-looking statements should be considered in light of those factors.
Investor Contact:
Datawatch Investor Relations
E: investor[.]datawatch.com - P: 978-441-2200 x8323
© 2015 Datawatch Corporation. Datawatch and the Datawatch logo are trademarks or registered trademarks of Datawatch Corporation in the United States and/or other countries. All other names are trademarks or registered trademarks of their respective companies.
|
sarah_bernardi[.]datawatch.com 
